About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT04190511

Characteristic and Modulation of Gut Microbiota on the Consequences of Pregnancy

Since the incidence of maternal obesity and gestational diabetes mellitus (GDM) is on the rise globally, how to improve the intrauterine environment of the offspring and prevent obesity and metabolic ...

Lead sponsor: Capital Medical University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Capital Medical University

Age

18 - 45 years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•Age 18 \~ 45 years
•single pregnancy
•enrollment week 8-12 + 6 weeks (based on the last menstrual period or B-ultrasound monitoring)
•BMI ≥ 25 kg / m2
•living in Beijing for at least 5 years

Exclusion Criteria

•Taking antibiotics, probiotics or prebiotics
•smoking regularly
•drinking alcohol
•assisted fertility technology conception
•mental illness who were unable to answer questions correctly or were unwilling to conduct questionnaire surveys
•history of bariatric surgery
•not following dietary recommendations
•Lactose intolerance
•milk protein allergy
•pre-pregnancy hypertension, diabetes, Hyperlipidemia, hepatitis, nephritis, gastrointestinal diseases (chronic gastritis, enteritis, gastric ulcer and duodenal ulcer, etc.) and a history of infectious diseases (hepatitis, tuberculosis, etc.).

Related studies

Glycemic Markers for Predicting Gestational Diabetes in Pregnant Women With Previous Bariatric Surgery

NCT07517406 · Gestational Diabetes Mellitus (GDM), Pregnancy Complications, and more

Lifestyle Interventions to Prevent Diabetes in U.S. Home Visiting Programs

NCT06988306 · Diabetes Mellitus, Gestational Diabetes Mellitus (GDM)

The Project for Managing Cardiometabolic Risk in Women Diagnosed With Gestational Diabetes Mellitus

NCT06648174 · Gestational Diabetes Mellitus, Continuous Glucose Monitoring

RECRUITINGPhase 2

Effectiveness Study of a Lifestyle Intervention Versus Metformin in Mothers With Recent Gestational Diabetes

NCT06948825 · Weight Loss, Gestational Diabetes Mellitus in Pregnancy, and more

RECRUITINGPhase 4

DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes

NCT06445946 · Gestational Diabetes Mellitus, Pregnancy, High Risk

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 2, 2021Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment375

Start dateDec 2019

Last updatedAug 2, 2021

Condition

Gestational Diabetes Mellitus Medical Nutrition Therapy Overweight/Obese Gut Microbiota Adverse Pregnancy Outcomes

Locations shown

Beijing Obstetrics and Gynecology Hospital,Capital Medical University

Beijing, Chaoyang

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 2, 2021Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions